The recent probable discovery at Yale University School of Medicine of an off-label use of the FDA approved arthritis drug Tofacitinib Citrate is great new news and brings new hope for new hair to over 5 million Alopecia sufferers in the USA alone.
Still no hope for new hair growth exists for women who suffer from the most common form of female hair loss, known as female pattern hair loss or Androgenetic Alopecia.
Most women with female pattern hair loss do not suffer from a receding hair line or a bald spot on top of the scalp, as men often do.
Instead, they have noticeable thinning the crown area.
Because of the shortened growth cycle, the hair is miniaturized. This can be a serious, if not devastating problem for women.
Even though dire, not all hope is gone.
For many years, New Image University has been educating the public and the hair replacement industry about non-invasive, non-surgical and immediate hair replacement solutions.
Jay Benjamin, Director of New Image University and renowned veteran hair replacement expert is available to discuss solutions and alternatives for women with female pattern hair loss.